The malignant social network: Cell-cell adhesion and communication in cancer stem cells

Cell Adhesion and Migration

Volumn 6, Issue 4, 2012, Pages 346-355

  Hale, James S ^a   Li, Meizhang ^a   Lathia, Justin D ^a,b,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Cancer stem cell; Cell adhesion; Cell cell communication

Indexed keywords

CADHERIN; CONNEXIN 43; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; JUNCTIONAL ADHESION MOLECULE A; NERVE CELL ADHESION MOLECULE;

BREAST CANCER; CANCER STEM CELL; CELL ADHESION; CELL COMMUNICATION; CELL HETEROGENEITY; CELL POPULATION; COLON CANCER; EXTRACELLULAR MATRIX; GAP JUNCTION; GLIOBLASTOMA; HUMAN; REVIEW; SQUAMOUS CELL CARCINOMA; STEM CELL NICHE; STROMA CELL; TUMOR MICROENVIRONMENT;

EID: 84867240957     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: 10.4161/cam.21294     Document Type: Review

References (147)

1. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-11; PMID:11689955; http://dx.doi.org/ 10.1038/35102167
2. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444:756-60; PMID:17051156; http://dx.doi.org/10.1038/ nature05236
3. Magee JA, Pender NP, Abrahams S, Thornton J, Delanty N, Fortune GM. A comparison of propofol and amobarbital for use in the Wada test. Seizure 2012; 21:399-401; PMID:22425425; http://dx.doi.org/10.1016/j.seizure.2012.02.001
4. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63:5821-8; PMID:14522905
5. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature 2004; 432:396-401; PMID:15549107; http://dx.doi.org/10.1038/nature03128
6. Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD, Steindler DA. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 2002; 39:193-206; PMID:12203386; http://dx.doi.org/10.1002/glia.10094
7. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A 2003; 100:15178-83; PMID:14645703; http://dx.doi.org/10.1073/pnas.2036535100
8. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004; 64:7011-21; PMID: 15466194; http://dx.doi.org/10.1158/0008-5472.CAN-04-1364
9. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003; 100:3983-8; PMID:12629218; http://dx.doi.org/10.1073/pnas. 0530291100
10. Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, Hotz S, et al. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 2005; 65:9328-37; PMID:16230395; http://dx.doi.org/10.1158/0008-5472.CAN-05-1343
11. Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, Gasser M, et al. Identification of cells initiating human melanomas. Nature 2008; 451:345-9; PMID:18202660; http://dx.doi.org/10.1038/nature06489
12. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445:106-10; PMID:17122772; http://dx.doi.org/10.1038/nature05372
13. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445:111-5; PMID:17122771; http://dx.doi.org/10.1038/nature05384
14. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005; 65:10946-51; PMID:16322242; http://dx.doi.org/10.1158/0008-5472.CAN-05-2018
15. Li Z, Wang H, Eyler CE, Hjelmeland AB, Rich JN. Turning cancer stem cells inside out: an exploration of glioma stem cell signaling pathways. J Biol Chem 2009; 284:16705-9; PMID:19286664; http://dx.doi.org/10.1074/jbc.R900013200
16. Malanchi I, Santamaria-Martínez A, Susanto E, Peng H, Lehr HA, Delaloye JF, et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 2012; 481:85-9; PMID:22158103; http://dx.doi.org/10.1038/nature10694
17. Lathia JD, Heddleston JM, Venere M, Rich JN. Deadly teamwork: neural cancer stem cells and the tumor microenvironment. Cell Stem Cell 2011; 8:482-5; PMID:21549324; http://dx.doi.org/10.1016/j.stem.2011.04.013
18. Cheng L, Wu Q, Guryanova OA, Huang Z, Huang Q, Rich JN, et al. Elevated invasive potential of glioblastoma stem cells. Biochem Biophys Res Commun 2011; 406:643-8; PMID:21371437; http://dx.doi.org/10.1016/j.bbrc.2011.02.123
19. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133:704-15; PMID:18485877; http://dx.doi.org/10.1016/j.cell.2008.03. 027
20. Friedl P, Alexander S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 2011; 147:992-1009; PMID:22118458; http://dx.doi.org/10.1016/j.cell.2011.11.016
21. Hu B, Kong LL, Matthews RT, Viapiano MS. The proteoglycan brevican binds to fibronectin after proteolytic cleavage and promotes glioma cell motility. J Biol Chem 2008; 283:24848-59; PMID:18611854; http://dx.doi.org/10.1074/jbc. M801433200
22. Hu B, Thirtamara-Rajamani KK, Sim H, Viapiano MS. Fibulin-3 is uniquely upregulated in malignant gliomas and promotes tumor cell motility and invasion. Mol Cancer Res 2009; 7:1756-70; PMID:19887559; http://dx.doi.org/10.1158/1541- 7786.MCR-09-0207
23. Mariotti A, Kedeshian PA, Dans M, Curatola AM, Gagnoux-Palacios L, Giancotti FG. EGF-R signaling through Fyn kinase disrupts the function of integrin alpha6beta4 at hemidesmosomes: role in epithelial cell migration and carcinoma invasion. J Cell Biol 2001; 155:447-58; PMID:11684709; http://dx.doi.org/10.1083/jcb.200105017
24. Schneller M, Vuori K, Ruoslahti E. Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF. EMBO J 1997; 16:5600-7; PMID:9312019; http://dx.doi.org/10.1093/emboj/ 16.18.5600
25. Soldi R, Mitola S, Strasly M, Defilippi P, Tarone G, Bussolino F. Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J 1999; 18:882-92; PMID:10022831; http://dx.doi.org/10.1093/ emboj/18.4.882
26. Lee OH, Xu J, Fueyo J, Fuller GN, Aldape KD, Alonso MM, et al. Expression of the receptor tyrosine kinase Tie2 in neoplastic glial cells is associated with integrin beta1-dependent adhesion to the extracellular matrix. Mol Cancer Res 2006; 4:915-26; PMID:17189382; http://dx.doi.org/10.1158/1541-7786.MCR-06- 0184
27. Soung YH, Clifford JL, Chung J. Crosstalk between integrin and receptor tyrosine kinase signaling in breast carcinoma progression. BMB Rep 2010; 43:311-8; PMID:20510013; http://dx.doi.org/10.5483/BMBRep.2010.43.5.311
28. Xu Z, Jin B. A novel interface consisting of homologous immunoglobulin superfamily members with multiple functions. Cell Mol Immunol 2010; 7:11-9; PMID:20081873; http://dx.doi.org/10.1038/cmi.2009.108
29. Crossin KL, Krushel LA. Cellular signaling by neural cell adhesion molecules of the immunoglobulin superfamily. Dev Dyn 2000; 218:260-79; PMID:10842356; http://dx.doi.org/10.1002/(SICI)1097-0177(200006)218:2,260::AID- DVDY3.3.0.CO;2-9
30. Ensslen SE, Rosdahl JA, Brady-Kalnay SM. The receptor protein tyrosine phosphatase mu, PTPmu, regulates histogenesis of the chick retina. Dev Biol 2003; 264:106-18; PMID:14623235; http://dx.doi.org/10.1016/j.ydbio.2003.08.009
31. Fotis L, Agrogiannis G, Vlachos IS, Pantopoulou A, Margoni A, Kostaki M, et al. Intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 at the early stages of atherosclerosis in a rat model. In Vivo 2012; 26:243-50; PMID:22351665
32. Nollet F, Kools P, van Roy F. Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members. J Mol Biol 2000; 299:551-72; PMID:10835267; http://dx.doi.org/10.1006/jmbi.2000.3777
33. Parisini E, Higgins JM, Liu JH, Brenner MB, Wang JH. The crystal structure of human E-cadherin domains 1 and 2, and comparison with other cadherins in the context of adhesion mechanism. J Mol Biol 2007; 373:401-11; PMID:17850815; http://dx.doi.org/10.1016/j.jmb.2007.08.011
34. Williams EJ, Williams G, Howell FV, Skaper SD, Walsh FS, Doherty P. Identification of an N-cadherin motif that can interact with the fibroblast growth factor receptor and is required for axonal growth. J Biol Chem 2001; 276:43879-86; PMID:11571292; http://dx.doi.org/10.1074/jbc.M105876200
35. Mateus AR, Seruca R, Machado JC, Keller G, Oliveira MJ, Suriano G, et al. EGFR regulates RhoA-GTP dependent cell motility in E-cadherin mutant cells. Hum Mol Genet 2007; 16:1639-47; PMID:17510211; http://dx.doi.org/10.1093/hmg/ddm113
36. Chen WS, Antic D, Matis M, Logan CY, Povelones M, Anderson GA, et al. Asymmetric homotypic interactions of the atypical cadherin flamingo mediate intercellular polarity signaling. Cell 2008; 133:1093-105; PMID:18555784; http://dx.doi.org/10.1016/j.cell.2008.04.048
37. Laprise P, Langlois MJ, Boucher MJ, Jobin C, Rivard N. Down-regulation of MEK/ERK signaling by Ecadherin-dependent PI3K/Akt pathway in differentiating intestinal epithelial cells. J Cell Physiol 2004; 199:32-9; PMID:14978732; http://dx.doi.org/10.1002/jcp.10432
38. Kam Y, Quaranta V. Cadherin-bound beta-catenin feeds into the Wnt pathway upon adherens junctions dissociation: evidence for an intersection between beta-catenin pools. PLoS One 2009; 4:e4580; PMID:19238201; http://dx.doi.org/10. 1371/journal.pone.0004580
39. De Santis G, Miotti S, Mazzi M, Canevari S, Tomassetti A. E-cadherin directly contributes to PI3K/AKT activation by engaging the PI3K-p85 regulatory subunit to adherens junctions of ovarian carcinoma cells. Oncogene 2009; 28:1206-17; PMID:19151754; http://dx.doi.org/10.1038/onc.2008.470
40. McCusker C, Cousin H, Neuner R, Alfandari D. Extracellular cleavage of cadherin-11 by ADAM metalloproteases is essential for Xenopus cranial neural crest cell migration. Mol Biol Cell 2009; 20:78-89; PMID:18946084; http://dx.doi.org/10.1091/mbc.E08-05-0535
41. von Schlippe M, Marshall JF, Perry P, Stone M, Zhu AJ, Hart IR. Functional interaction between Ecadherin and alphav-containing integrins in carcinoma cells. J Cell Sci 2000; 113:425-37; PMID:10639330
42. Perrais M, Chen X, Perez-Moreno M, Gumbiner BM. E-cadherin homophilic ligation inhibits cell growth and epidermal growth factor receptor signaling independently of other cell interactions. Mol Biol Cell 2007; 18:2013-25; PMID:17392517; http://dx.doi.org/10.1091/mbc.E06-04-0348
43. Aurrand-Lions M, Johnson-Leger C, Wong C, Du Pasquier L, Imhof BA. Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members. Blood 2001; 98:3699-707; PMID:11739175; http://dx.doi.org/10.1182/blood.V98.13.3699
44. Weber C, Fraemohs L, Dejana E. The role of junctional adhesion molecules in vascular inflammation. Nat Rev Immunol 2007; 7:467-77; PMID:17525755; http://dx.doi.org/10.1038/nri2096
45. Bradfield PF, Nourshargh S, Aurrand-Lions M, Imhof BA. JAM family and related proteins in leukocyte migration (Vestweber series). Arterioscler Thromb Vasc Biol 2007; 27:2104-12; PMID:17615384; http://dx.doi.org/10.1161/ATVBAHA. 107.147694
46. Prota AE, Campbell JA, Schelling P, Forrest JC, Watson MJ, Peters TR, et al. Crystal structure of human junctional adhesion molecule 1: implications for reovirus binding. Proc Natl Acad Sci U S A 2003; 100:5366-71; PMID:12697893; http://dx.doi.org/10.1073/pnas.0937718100
47. Guglielmi KM, Johnson EM, Stehle T, Dermody TS. Attachment and cell entry of mammalian orthoreovirus. Curr Top Microbiol Immunol 2006; 309:1-38; PMID:16909895; http://dx.doi.org/10.1007/3-540-30773-7-1
48. Severson EA, Jiang L, Ivanov AI, Mandell KJ, Nusrat A, Parkos CA. Cis-dimerization mediates function of junctional adhesion molecule A. Mol Biol Cell 2008; 19:1862-72; PMID:18272784; http://dx.doi.org/10.1091/mbc.E07-09-0869
49. Kostrewa D, Brockhaus M, D'Arcy A, Dale GE, Nelboeck P, Schmid G, et al. X-ray structure of junctional adhesion molecule: structural basis for homophilic adhesion via a novel dimerization motif. EMBO J 2001; 20:4391-8; PMID:11500366; http://dx.doi.org/10.1093/emboj/20.16.4391
50. Liu Y, Nusrat A, Schnell FJ, Reaves TA, Walsh S, Pochet M, et al. Human junction adhesion molecule regulates tight junction resealing in epithelia. J Cell Sci 2000; 113:2363-74; PMID:10852816
51. Yamamoto T, Harada N, Kano K, Taya S, Canaani E, Matsuura Y, et al. The Ras target AF-6 interacts with ZO-1 and serves as a peripheral component of tight junctions in epithelial cells. J Cell Biol 1997; 139:785-95; PMID:9348294; http://dx.doi.org/10.1083/jcb.139.3.785
52. Ebnet K, Schulz CU, Meyer Zu Brickwedde MK, Pendl GG, Vestweber D. Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1. J Biol Chem 2000; 275:27979-88; PMID:10856295
53. Severson EA, Lee WY, Capaldo CT, Nusrat A, Parkos CA. Junctional adhesion molecule A interacts with Afadin and PDZ-GEF2 to activate Rap1A, regulate beta1 integrin levels, and enhance cell migration. Mol Biol Cell 2009; 20:1916-25; PMID:19176753; http://dx.doi.org/10.1091/mbc.E08-10-1014
54. Cismasiu VB, Denes SA, Reiländer H, Michel H, Szedlacsek SE. The MAM (meprin/A5-protein/ PTPmu) domain is a homophilic binding site promoting the lateral dimerization of receptor-like protein-tyrosine phosphatase mu. J Biol Chem 2004; 279:26922-31; PMID:15084579; http://dx.doi.org/10.1074/jbc.M313115200
55. Oblander SA, Brady-Kalnay SM. Distinct PTPmu-associated signaling molecules differentially regulate neurite outgrowth on E-, N-, and R-cadherin. Mol Cell Neurosci 2010; 44:78-93; PMID:20197094; http://dx.doi.org/10.1016/j. mcn.2010.02.005
56. Sui XF, Kiser TD, Hyun SW, Angelini DJ, Del Vecchio RL, Young BA, et al. Receptor protein tyrosine phosphatase micro regulates the paracellular pathway in human lung microvascular endothelia. Am J Pathol 2005; 166:1247-58; PMID:15793303; http://dx.doi.org/10.1016/S0002-9440(10)62343-7
57. Brady-Kalnay SM, Rimm DL, Tonks NK. Receptor protein tyrosine phosphatase PTPmu associates with cadherins and catenins in vivo. J Cell Biol 1995; 130:977-86; PMID:7642713; http://dx.doi.org/10.1083/jcb.130.4.977
58. Giepmans BN, Feiken E, Gebbink MF, Moolenaar WH. Association of connexin43 with a receptor protein tyrosine phosphatase. Cell Commun Adhes 2003; 10:201-5; PMID:14681016
59. Soroka V, Kolkova K, Kastrup JS, Diederichs K, Breed J, Kiselyov VV, et al. Structure and interactions of NCAM Ig1-2-3 suggest a novel zipper mechanism for homophilic adhesion. Structure 2003; 11:1291-301; PMID:14527396; http://dx.doi.org/10.1016/j.str.2003.09.006
60. Francavilla C, Cattaneo P, Berezin V, Bock E, Ami D, de Marco A, et al. The binding of NCAM to FGFR1 induces a specific cellular response mediated by receptor trafficking. J Cell Biol 2009; 187:1101-16; PMID:20038681; http://dx.doi.org/10.1083/jcb.200903030
61. Hansen SM, Berezin V, Bock E. Signaling mechanisms of neurite outgrowth induced by the cell adhesion molecules NCAM and N-cadherin. Cell Mol Life Sci 2008; 65:3809-21; PMID:18791849; http://dx.doi.org/10.1007/s00018-008-8290-0
62. Liu R, Shi Y, Yang HJ, Wang L, Zhang S, Xia YY, et al. Neural cell adhesion molecule potentiates the growth of murine melanoma via β-catenin signaling by association with fibroblast growth factor receptor and glycogen synthase kinase-3β. J Biol Chem 2011; 286:26127-37; PMID:21628472; http://dx.doi.org/10.1074/jbc.M111.237297
63. Cavallaro U, Niedermeyer J, Fuxa M, Christofori G. N-CAM modulates tumour-cell adhesion to matrix by inducing FGF-receptor signalling. Nat Cell Biol 2001; 3:650-7; PMID:11433297; http://dx.doi.org/10.1038/35083041
64. Hayflick JS, Kilgannon P, Gallatin WM. The intercellular adhesion molecule (ICAM) family of proteins. New members and novel functions. Immunol Res 1998; 17:313-27; PMID:9638475; http://dx.doi.org/10.1007/BF02786454
65. Mendez MP, Morris SB, Wilcoxen S, Du M, Monroy YK, Remmer H, et al. Disparate mechanisms of sICAM-1 production in the peripheral lung: contrast between alveolar epithelial cells and pulmonary microvascular endothelial cells. Am J Physiol Lung Cell Mol Physiol 2008; 294:L807-14; PMID:18281605; http://dx.doi.org/10.1152/ajplung.00398.2007
66. Pforte A, Schiessler A, Gais P, von Kress S, Beer B, Riethmüller G, et al. Expression of the adhesion molecule ICAM-1 on alveolar macrophages and in serum in extrinsic allergic alveolitis. Respiration 1993; 60:221-6; PMID:7903468; http://dx.doi.org/10.1159/000196203
67. Martinelli R, Gegg M, Longbottom R, Adamson P, Turowski P, Greenwood J. ICAM-1-mediated endothelial nitric oxide synthase activation via calcium and AMP-activated protein kinase is required for transendothelial lymphocyte migration. Mol Biol Cell 2009; 20:995-1005; PMID:19073885; http://dx.doi.org/10. 1091/mbc.E08-06-0636
68. Crook MF, Southgate KM, Newby AC. Both ICAM-1- and VCAM-1-integrin interactions are important in mediating monocyte adhesion to human saphenous vein. J Vasc Res 2002; 39:221-9; PMID:12097820; http://dx.doi.org/10.1159/ 000063687
69. Rahn JJ, Chow JW, Horne GJ, Mah BK, Emerman JT, Hoffman P, et al. MUC1 mediates transendothelial migration in vitro by ligating endothelial cell ICAM-1. Clin Exp Metastasis 2005; 22:475-83; PMID:16320110; http://dx.doi.org/ 10.1007/s10585-005-3098-x
70. Boyd JH, Chau EH, Tokunanga C, Bateman RM, Haljan G, Davani EY, et al. Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism. Crit Care 2008; 12:R2; PMID:18173852; http://dx.doi.org/10.1186/ cc6213
71. Chen L, Zhou S. "CRASH"ing with the worm: insights into L1CAM functions and mechanisms. Dev Dyn 2010; 239:1490-501; PMID:20225255
72. Haspel J, Grumet M. The L1CAM extracellular region: a multi-domain protein with modular and cooperative binding modes. Front Biosci 2003; 8:s1210-25; PMID:12957823; http://dx.doi.org/10.2741/1108
73. Friedlander DR, Milev P, Karthikeyan L, Margolis RK, Margolis RU, Grumet M. The neuronal chondroitin sulfate proteoglycan neurocan binds to the neural cell adhesion molecules Ng-CAM/L1/NILE and N-CAM, and inhibits neuronal adhesion and neurite outgrowth. J Cell Biol 1994; 125:669-80; PMID:7513709; http://dx.doi.org/10.1083/jcb.125.3.669
74. Kiefel H, Bondong S, Erbe-Hoffmann N, Hazin J, Riedle S, Wolf J, et al. L1CAM-integrin interaction induces constitutive NF-kappaB activation in pancreatic adenocarcinoma cells by enhancing IL-1beta expression. Oncogene 2010; 29:4766-78; PMID:20543863; http://dx.doi.org/10.1038/onc.2010.230
75. Nishimura T, Fukata Y, Kato K, Yamaguchi T, Matsuura Y, Kamiguchi H, et al. CRMP-2 regulates polarized Numb-mediated endocytosis for axon growth. Nat Cell Biol 2003; 5:819-26; PMID:12942088; http://dx.doi.org/10.1038/ncb1039
76. González-Mariscal L, Tapia R, Chamorro D. Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta 2008; 1778:729-56; PMID:17950242; http://dx.doi.org/10.1016/j.bbamem.2007.08.018
77. Ikenouchi J, Matsuda M, Furuse M, Tsukita S. Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail. J Cell Sci 2003; 116:1959-67; PMID:12668723; http://dx.doi.org/10.1242/jcs.00389
78. Zhong X, Rescorla FJ. Cell surface adhesion molecules and adhesion-initiated signaling: understanding of anoikis resistance mechanisms and therapeutic opportunities. Cell Signal 2012; 24:393-401; PMID:22024283; http://dx.doi.org/10.1016/j.cellsig.2011.10.005
79. Moh MC, Shen S. The roles of cell adhesion molecules in tumor suppression and cell migration: a new paradox. Cell Adh Migr 2009; 3:334-6; PMID:19949308; http://dx.doi.org/10.4161/cam.3.4.9246
80. Vaillant F, Asselin-Labat ML, Shackleton M, Forrest NC, Lindeman GJ, Visvader JE. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. Cancer Res 2008; 68:7711-7; PMID:18829523; http://dx.doi.org/10.1158/0008-5472.CAN-08-1949
81. Vassilopoulos A, Wang RH, Petrovas C, Ambrozak D, Koup R, Deng CX. Identification and characterization of cancer initiating cells from BRCA1 related mammary tumors using markers for normal mammary stem cells. Int J Biol Sci 2008; 4:133-42; PMID:18461147; http://dx.doi.org/10.7150/ijbs.4.133
82. Lathia JD, Gallagher J, Heddleston JM, Wang J, Eyler CE, Macswords J, et al. Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell 2010; 6:421-32; PMID:20452317; http://dx.doi.org/10.1016/j.stem.2010.02.018
83. Patrawala L, Calhoun-Davis T, Schneider-Broussard R, Tang DG. Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells. Cancer Res 2007; 67:6796-805; PMID:17638891; http://dx.doi.org/10.1158/0008-5472.CAN- 07-0490
84. Schober M, Fuchs E. Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-βand integrin/focal adhesion kinase (FAK) signaling. Proc Natl Acad Sci U S A 2011; 108:10544-9; PMID:21670270; http://dx.doi.org/10.1073/pnas.1107807108
85. Dang D, Ramos DM. Identification of alphavbeta6-positive stem cells in oral squamous cell carcinoma. Anticancer Res 2009; 29:2043-9; PMID:19528463
86. Zhang M, Behbod F, Atkinson RL, Landis MD, Kittrell F, Edwards D, et al. Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Res 2008; 68:4674-82; PMID:18559513; http://dx.doi.org/10.1158/ 0008-5472.CAN-07-6353
87. Cariati M, Naderi A, Brown JP, Smalley MJ, Pinder SE, Caldas C, et al. Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line. Int J Cancer 2008; 122:298-304; PMID:17935134; http://dx.doi.org/10.1002/ijc.23103
88. Mulholland DJ, Xin L, Morim A, Lawson D, Witte O, Wu H. Lin-Sca-1+CD49fhigh stem/progenitors are tumor-initiating cells in the Pten-null prostate cancer model. Cancer Res 2009; 69:8555-62; PMID:19887604; http://dx.doi.org/10.1158/0008-5472.CAN-08-4673
89. Ali HR, Dawson SJ, Blows FM, Provenzano E, Pharoah PD, Caldas C. Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance. Breast Cancer Res 2011; 13:R118; PMID:22112299; http://dx.doi.org/10.1186/bcr3061
90. Hurt EM, Chan K, Serrat MA, Thomas SB, Veenstra TD, Farrar WL. Identification of vitronectin as an extrinsic inducer of cancer stem cell differentiation and tumor formation. Stem Cells 2010; 28:390-8; PMID:19998373
91. Ramirez NE, Zhang Z, Madamanchi A, Boyd KL, O'Rear LD, Nashabi A, et al. The α2β1 integrin is a metastasis suppressor in mouse models and human cancer. J Clin Invest 2011; 121:226-37; PMID:21135504; http://dx.doi.org/10.1172/JCI42328
92. van den Hoogen C, van der Horst G, Cheung H, Buijs JT, Pelger RC, van der Pluijm G. Integrin αvexpression is required for the acquisition of a metastatic stem/progenitor cell phenotype in human prostate cancer. Am J Pathol 2011; 179:2559-68; PMID:21907176; http://dx.doi.org/10.1016/j.ajpath.2011.07.011
93. van der Horst G, van den Hoogen C, Buijs JT, Cheung H, Bloys H, Pelger RC, et al. Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer. Neoplasia 2011; 13:516-25; PMID:21677875
94. Lathia JD, Patton B, Eckley DM, Magnus T, Mughal MR, Sasaki T, et al. Patterns of laminins and integrins in the embryonic ventricular zone of the CNS. J Comp Neurol 2007; 505:630-43; PMID:17948866; http://dx.doi.org/10.1002/cne. 21520
95. Kazanis I, Lathia JD, Vadakkan TJ, Raborn E, Wan R, Mughal MR, et al. Quiescence and activation of stem and precursor cell populations in the subependymal zone of the mammalian brain are associated with distinct cellular and extracellular matrix signals. J Neurosci 2010; 30:9771-81; PMID:20660259; http://dx.doi.org/10.1523/JNEUROSCI.0700-10.2010
96. Strumane K, Berx G, Van Roy F. Cadherins in cancer. Handb Exp Pharmacol 2004:69-103.
97. Bae KM, Parker NN, Dai Y, Vieweg J, Siemann DW. E-cadherin plasticity in prostate cancer stem cell invasion. Am J Cancer Res 2011; 1:71-84; PMID:21968440
98. Berx G, Van Roy F. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res 2001; 3:289-93; PMID:11597316; http://dx.doi.org/10.1186/bcr309
99. Vieira AF, Ricardo S, Ablett MP, Dionísio MR, Mendes N, Albergaria A, et al. P-cadherin is coexpressed with CD44 and CD49f and mediates stem cell properties in basal-like breast cancer. Stem Cells 2012; 30:854-64; PMID:22389315; http://dx.doi.org/10.1002/stem.1075
100. McSherry EA, McGee SF, Jirstrom K, Doyle EM, Brennan DJ, Landberg G, et al. JAM-A expression positively correlates with poor prognosis in breast cancer patients. Int J Cancer 2009; 125:1343-51; PMID:19533747; http://dx.doi.org/10. 1002/ijc.24498
101. McSherry EA, Brennan K, Hudson L, Hill AD, Hopkins AM. Breast cancer cell migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase. Breast Cancer Res 2011; 13:R31; PMID:21429211; http://dx.doi.org/10.1186/bcr2853
102. Naik MU, Naik TU, Suckow AT, Duncan MK, Naik UP. Attenuation of junctional adhesion molecule-A is a contributing factor for breast cancer cell invasion. Cancer Res 2008; 68:2194-203; PMID:18381425; http://dx.doi.org/10. 1158/0008-5472.CAN-07-3057
103. Sugano Y, Takeuchi M, Hirata A, Matsushita H, Kitamura T, Tanaka M, et al. Junctional adhesion molecule-A, JAM-A, is a novel cell-surface marker for long-term repopulating hematopoietic stem cells. Blood 2008; 111:1167-72; PMID:17986666; http://dx.doi.org/10.1182/blood-2007-03-081554
104. Burgoyne AM, Palomo JM, Phillips-Mason PJ, Burden-Gulley SM, Major DL, Zaremba A, et al. PTPmu suppresses glioma cell migration and dispersal. Neuro Oncol 2009; 11:767-78; PMID:19304959; http://dx.doi.org/10.1215/15228517-2009- 019
105. Hellberg CB, Burden-Gulley SM, Pietz GE, Brady-Kalnay SM. Expression of the receptor protein-tyrosine phosphatase, PTPmu, restores E-cadherin-dependent adhesion in human prostate carcinoma cells. J Biol Chem 2002; 277:11165-73; PMID:11801604; http://dx.doi.org/10.1074/jbc.M112157200
106. Burgoyne AM, Phillips-Mason PJ, Burden-Gulley SM, Robinson S, Sloan AE, Miller RH, et al. Proteolytic cleavage of protein tyrosine phosphatase μ regulates glioblastoma cell migration. Cancer Res 2009; 69:6960-8; PMID:19690139; http://dx.doi.org/10.1158/0008-5472.CAN-09-0863
107. Burden-Gulley SM, Gates TJ, Burgoyne AM, Cutter JL, Lodowski DT, Robinson S, et al. A novel molecular diagnostic of glioblastomas: detection of an extracellular fragment of protein tyrosine phosphatase mu. Neoplasia 2010; 12:305-16; PMID:20360941
108. Kaur H, Burden-Gulley SM, Phillips-Mason PJ, Basilion JP, Sloan AE, Brady-Kalnay SM. Protein tyrosine phosphatase mu regulates glioblastoma cell growth and survival in vivo. Neuro Oncol 2012; 14:561-73; PMID:22505657; http://dx.doi.org/10.1093/neuonc/nos066
109. Zecchini S, Cavallaro U. Neural cell adhesion molecule in cancer: expression and mechanisms. Adv Exp Med Biol 2010; 663:319-33; PMID:20017031; http://dx.doi.org/10.1007/978-1-4419-1170-4-20
110. Roesler J, Srivatsan E, Moatamed F, Peters J, Livingston EH. Tumor suppressor activity of neural cell adhesion molecule in colon carcinoma. Am J Surg 1997; 174:251-7; PMID:9324132; http://dx.doi.org/10.1016/S0002-9610(97) 00142-6
111. Sasaki H, Yoshida K, Ikeda E, Asou H, Inaba M, Otani M, et al. Expression of the neural cell adhesion molecule in astrocytic tumors: an inverse correlation with malignancy. Cancer 1998; 82:1921-31; PMID:9587126; http://dx.doi.org/10.1002/(SICI)1097-0142(19980515)82:10〈1921:: AID-CNCR16〉3.0.CO;2-V
112. Sjöstrand D, Ibáñez CF. Insights into GFRalpha1 regulation of neural cell adhesion molecule (NCAM) function from structure-function analysis of the NCAM/GFRalpha1 receptor complex. J Biol Chem 2008; 283:13792-8; PMID:18353777; http://dx.doi.org/10.1074/jbc.M800283200
113. Amoureux MC, Coulibaly B, Chinot O, Loundou A, Metellus P, Rougon G, et al. Polysialic acid neural cell adhesion molecule (PSA-NCAM) is an adverse prognosis factor in glioblastoma, and regulates olig2 expression in glioma cell lines. BMC Cancer 2010; 10:91; PMID:20219118; http://dx.doi.org/10.1186/1471- 2407-10-91
114. Spyra M, Kluwe L, Hagel C, Nguyen R, Panse J, Kurtz A, et al. Cancer stem cell-like cells derived from malignant peripheral nerve sheath tumors. PLoS One 2011; 6:e21099; PMID:21695156; http://dx.doi.org/10.1371/journal.pone.0021099
115. Schröder C, Witzel I, Müller V, Krenkel S, Wirtz RM, Jänicke F, et al. Prognostic value of intercellular adhesion molecule (ICAM)-1 expression in breast cancer. J Cancer Res Clin Oncol 2011; 137:1193-201; PMID:21590495; http://dx.doi.org/10.1007/s00432-011-0984-2
116. Rosette C, Roth RB, Oeth P, Braun A, Kammerer S, Ekblom J, et al. Role of ICAM1 in invasion of human breast cancer cells. Carcinogenesis 2005; 26:943-50; PMID:15774488; http://dx.doi.org/10.1093/carcin/bgi070
117. Hamaï A, Meslin F, Benlalam H, Jalil A, Mehrpour M, Faure F, et al. ICAM-1 has a critical role in the regulation of metastatic melanoma tumor susceptibility to CTL lysis by interfering with PI3K/AKT pathway. Cancer Res 2008; 68:9854-64; PMID:19047166; http://dx.doi.org/10.1158/0008-5472.CAN-08-0719
118. Maeda K, Kang SM, Sawada T, Nishiguchi Y, Yashiro M, Ogawa Y, et al. Expression of intercellular adhesion molecule-1 and prognosis in colorectal cancer. Oncol Rep 2002; 9:511-4; PMID:11956618
119. Tian MM, Sun Y, Li ZW, Wu Y, Zhao AL, Li JY. Polymorphisms of ICAM-1 are associated with gastric cancer risk and prognosis. World J Gastroenterol 2012; 18:368-74; PMID:22294843; http://dx.doi.org/10.3748/wjg.v18.i4.368
120. Levina V, Marrangoni AM, DeMarco R, Gorelik E, Lokshin AE. Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One 2008; 3:e3077; PMID: 18728788; http://dx.doi.org/10.1371/ journal.pone.0003077
121. Sebens Müerköster S, Werbing V, Sipos B, Debus MA, Witt M, Grossmann M, et al. Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells. Oncogene 2007; 26:2759-68; PMID:17086212; http://dx.doi.org/10.1038/sj.onc.1210076
122. Cheng L, Wu Q, Huang Z, Guryanova OA, Huang Q, Shou W, et al. L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1. EMBO J 2011; 30:800-13; PMID:21297581; http://dx.doi.org/10.1038/emboj. 2011.10
123. Kaifi JT, Reichelt U, Quaas A, Schurr PG, Wachowiak R, Yekebas EF, et al. L1 is associated with micrometastatic spread and poor outcome in colorectal cancer. Mod Pathol 2007; 20:1183-90; PMID:17873897; http://dx.doi.org/10.1038/ modpathol.3800955
124. Thies A, Schachner M, Moll I, Berger J, Schulze HJ, Brunner G, et al. Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma. Eur J Cancer 2002; 38:1708-16; PMID:12175686; http://dx.doi.org/10.1016/S0959-8049(02)00105-3
125. Allory Y, Matsuoka Y, Bazille C, Christensen EI, Ronco P, Debiec H. The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas. Clin Cancer Res 2005; 11:1190-7; PMID:15709188
126. Yang M, Li Y, Chilukuri K, Brady OA, Boulos MI, Kappes JC, et al. L1 stimulation of human glioma cell motility correlates with FAK activation. J Neurooncol 2011; 105:27-44; PMID:21373966; http://dx.doi.org/10.1007/s11060-011- 0557-x
127. Bao S, Wu Q, Li Z, Sathornsumetee S, Wang H, McLendon RE, et al. Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res 2008; 68:6043-8; PMID:18676824; http://dx.doi.org/10.1158/0008-5472.CAN-08-1079
128. Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010; 29:4741-51; PMID:20531305; http://dx.doi.org/10.1038/onc.2010.215
129. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, et al. A reciprocal repression between ZEB1 and members of the miR-200 family
130. Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 2010; 12:R68; PMID:20813035; http://dx.doi.org/10.1186/bcr2635
131. Turksen K. Claudins and cancer stem cells. Stem Cell Rev 2011; 7:797-8; PMID:21526417; http://dx.doi.org/10.1007/s12015-011-9267-1
132. Trosko JE. The role of stem cells and gap junctions as targets for cancer chemoprevention and chemotherapy. Biomed Pharmacother 2005; 59(Suppl 2):S326-31; PMID:16507402; http://dx.doi.org/10.1016/S0753-3322(05)80065-4
133. Trosko JE, Chang CC, Upham BL, Tai MH. Ignored hallmarks of carcinogenesis: stem cells and cell-cell communication. Ann N Y Acad Sci 2004; 1028:192-201; PMID:15650245; http://dx.doi.org/10.1196/annals.1322.023
134. Cai J, Cheng A, Luo Y, Lu C, Mattson MP, Rao MS, et al. Membrane properties of rat embryonic multipotent neural stem cells. J Neurochem 2004; 88:212-26; PMID:14675165; http://dx.doi.org/10.1046/j.1471-4159.2003.02184.x
135. Cheng A, Tang H, Cai J, Zhu M, Zhang X, Rao M, et al. Gap junctional communication is required to maintain mouse cortical neural progenitor cells in a proliferative state. Dev Biol 2004; 272:203-16; PMID:15242801; http://dx.doi.org/10.1016/j.ydbio.2004.04.031
136. Elias LA, Wang DD, Kriegstein AR. Gap junction adhesion is necessary for radial migration in the neocortex. Nature 2007; 448:901-7; PMID:17713529; http://dx.doi.org/10.1038/nature06063
137. Gonzalez-Nieto D, Li L, Kohler A, Ghiaur G, Ishikawa E, Sengupta A, et al. Connexin-43 in the osteogenic BM niche regulates its cellular composition and the bidirectional traffic of hematopoietic stem cells and progenitors. Blood 2012; 119:5144-54; PMID:22498741; http://dx.doi.org/10.1182/blood-2011-07- 368506
138. Soroceanu L, Manning TJ, Jr., Sontheimer H. Reduced expression of connexin-43 and functional gap junction coupling in human gliomas. Glia 2001; 33:107-17; PMID:11180508; http://dx.doi.org/10.1002/1098-1136 (200102)33:2〈107::AID-GLIA1010〉3.0.CO;2-4
139. Yu SC, Xiao HL, Jiang XF, Wang QL, Li Y, Yang XJ, et al. Connexin 43 reverses malignant phenotypes of glioma stem cells by modulating E-cadherin. Stem Cells 2012; 30:108-20; PMID:22131169; http://dx.doi.org/10.1002/stem.1685
140. King TJ, Fukushima LH, Yasui Y, Lampe PD, Bertram JS. Inducible expression of the gap junction protein connexin43 decreases the neoplastic potential of HT-1080 human fibrosarcoma cells in vitro and in vivo. Mol Carcinog 2002; 35:29-41; PMID:12203365; http://dx.doi.org/10.1002/mc.10071
141. Kawasaki Y, Omori Y, Li Q, Nishikawa Y, Yoshioka T, Yoshida M, et al. Cytoplasmic accumulation of connexin32 expands cancer stem cell population in human HuH7 hepatoma cells by enhancing its self-renewal. Int J Cancer 2011; 128:51-62; PMID:20209499; http://dx.doi.org/10.1002/ijc.25308
142. Paraguassú-Braga FH, Borojevic R, Bouzas LF, Barcinski MA, Bonomo A. Bone marrow stroma inhibits proliferation and apoptosis in leukemic cells through gap junction-mediated cell communication. Cell Death Differ 2003; 10:1101-8; PMID:12934084; http://dx.doi.org/10.1038/sj.cdd.4401279
143. Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, Hjelmeland AB, et al. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 2006; 66:7843-8; PMID:16912155; http://dx.doi.org/10. 1158/0008-5472.CAN-06-1010
144. Wang H, Lathia JD,Wu Q, Wang J, Li Z, Heddleston JM, et al. Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth. Stem Cells 2009; 27:2393-404; PMID:19658188; http://dx.doi.org/10.1002/stem.188
145. Vermeulen L, Todaro M, de Sousa Mello F, Sprick MR, Kemper K, Perez Alea M, et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci U S A 2008; 105:13427-32; PMID:18765800; http://dx.doi.org/10.1073/pnas.0805706105
146. Kirkland SC, Ying H. Alpha2beta1 integrin regulates lineage commitment in multipotent human colorectal cancer cells. J Biol Chem 2008; 283:27612-9; PMID:18664572; http://dx.doi.org/10.1074/jbc.M802932200
147. Wu JJ, Cantor A, Moscinski LC. beta2 Integrins are characteristically absent in acute promyelocytic leukemia and rapidly upregulated in vivo upon differentiation with all-trans retinoic acid. Leuk Res 2007; 31:49-57; PMID:16764927; http://dx.doi.org/10.1016/j.leukres.2006.04.012